Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06683768 · ClinicalTrials.gov registry record
A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 40,563
- Enrollment target
NCT06683768: Completed study, sponsored by Novartis Pharmaceuticals.
NCT06683768 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 40,563 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06683768 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 40,563 participants
- Enrollment target
Study Summary
This was a non-interventional, secondary use of data, retrospective, cohort study. The data extracted in this study was used as secondary use of collected patient information in the database, Japan Medical Data Survey (JAMDAS), owned by M3 Inc. (Tokyo, Japan). JAMDAS is a database that aggregates medical information and is constructed mainly from electronic medical record information of medical institutions, allowing real-time extraction of information entered in medical records, such as prescription status including drug switching and continuation, laboratory values, clinical evaluation scores, and comorbidities etc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,563 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2023-11-08 |
What the finished NCT06683768 record still lists
NCT06683768 is an observational study that tracks outcomes without assigning an intervention. Its 40,563 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06683768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06683768 about?
NCT06683768 is a clinical study titled "A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension". This was a non-interventional, secondary use of data, retrospective, cohort study. The data extracted in this study was used as secondary use of collected patient information in the database, Japan Medical Data Survey (JAMDAS), owned by M3 Inc. (Tokyo, Japan). JAMDAS is a database that aggregates me...
What is the current status of trial NCT06683768?
This trial is currently completed. The enrollment target is 40,563 participants. The study started on 2023-02-28. Estimated completion is 2023-11-08.
Who is sponsoring clinical trial NCT06683768?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI